{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:13:53Z","timestamp":1774545233048,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The background parenchymal enhancement at breast magnetic resonance imaging use to predict breast cancer attracts many searchers to draw a possible relationship. However, the results of their relationships were conflicting. This meta-analysis was performed to assess breast cancer frequency associations with background parenchymal enhancement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic literature search up to January 2020 was performed to detect studies recording associations between breast cancer frequency and background parenchymal enhancement. We found thirteen studies including 13,788 women at the start with 4046 breast cancer. We calculated the odds ratio (OR) and the 95% confidence intervals (CIs) between breast cancer frequency and background parenchymal enhancement by the dichotomous technique with a random or fixed-effect model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Women with minimal or mild background parenchymal enhancement at breast magnetic resonance imaging did not have any risk of breast cancer compared to control women (OR, 1.20; 95% CI 0.54\u20132.67). However, high background parenchymal enhancement at breast magnetic resonance imaging (OR, 2.66; 95% CI 1.36\u20135.19) and moderate (OR, 2.51; 95% CI 1.49\u20134.21) was associated with a significantly higher rate of breast cancer frequency compared to control women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our meta-analysis showed that the women with high and moderate background parenchymal enhancement at breast magnetic resonance imaging have higher risks, up to 2.66 fold, of breast cancer. We suggest that women with high or moderate background parenchymal enhancement at breast magnetic resonance imaging to be scheduled for more frequent follow-up and screening for breast cancer to avoid any complications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12880-021-00566-8","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T22:25:52Z","timestamp":1613859952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Na","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanshui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2282-7792","authenticated-orcid":false,"given":"Wei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"issue":"7","key":"566_CR1","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.ejrad.2011.04.059","volume":"81","author":"T Uematsu","year":"2012","unstructured":"Uematsu T, Kasami M, Watanabe J. Should breast magnetic resonance imaging be performed with adjustment for the phase in patients\u2019 menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast magnetic resonance imaging without adjusting for the phase in patients\u2019 menstrual cycle. Eur J Radiol. 2012;81(7):1539\u201342.","journal-title":"Eur J Radiol"},{"key":"566_CR2","doi-asserted-by":"crossref","unstructured":"D\u2019Orsi, C., L. Bassett, and S. Feig, Breast imaging reporting and data system (BI-RADS). Breast imaging atlas, 4th edn. American College of Radiology, Reston, 2018.","DOI":"10.1093\/med\/9780190270261.003.0005"},{"issue":"12","key":"566_CR3","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/s00330-012-2553-8","volume":"22","author":"V King","year":"2012","unstructured":"King V, et al. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast magnetic resonance imaging. Eur Radiol. 2012;22(12):2641\u20137.","journal-title":"Eur Radiol"},{"issue":"3","key":"566_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.rcl.2014.02.008","volume":"52","author":"CL Mercado","year":"2014","unstructured":"Mercado CL. BI-RADS update. Radiol Clin. 2014;52(3):481\u20137.","journal-title":"Radiol Clin"},{"issue":"1","key":"566_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2214\/AJR.10.4550","volume":"196","author":"NM Hambly","year":"2011","unstructured":"Hambly NM, et al. Background parenchymal enhancement on baseline screening breast magnetic resonance imaging: impact on biopsy rate and short-interval follow-up. Am J Roentgenol. 2011;196(1):218\u201324.","journal-title":"Am J Roentgenol"},{"issue":"4","key":"566_CR6","doi-asserted-by":"publisher","first-page":"W373","DOI":"10.2214\/AJR.10.6272","volume":"198","author":"WB DeMartini","year":"2012","unstructured":"DeMartini WB, et al. Background parenchymal enhancement on breast magnetic resonance imaging: impact on diagnostic performance. Am J Roentgenol. 2012;198(4):W373\u201380.","journal-title":"Am J Roentgenol"},{"issue":"1","key":"566_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1148\/rg.341135034","volume":"34","author":"CS Giess","year":"2014","unstructured":"Giess CS, et al. Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation. Radiographics. 2014;34(1):234\u201347.","journal-title":"Radiographics"},{"issue":"2","key":"566_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1148\/radiol.2015142304","volume":"276","author":"BN Dontchos","year":"2015","unstructured":"Dontchos BN, et al. Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk? Radiology. 2015;276(2):371\u201380.","journal-title":"Radiology"},{"issue":"1","key":"566_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1148\/radiol.11102156","volume":"260","author":"V King","year":"2011","unstructured":"King V, et al. Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology. 2011;260(1):50\u201360.","journal-title":"Radiology"},{"issue":"3","key":"566_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1148\/radiol.15142192","volume":"276","author":"BH van der Velden","year":"2015","unstructured":"van der Velden BH, et al. Association between parenchymal enhancement of the contralateral breast in dynamic contrast-enhanced MR imaging and outcome of patients with unilateral invasive breast cancer. Radiology. 2015;276(3):675\u201385.","journal-title":"Radiology"},{"issue":"1088","key":"566_CR11","doi-asserted-by":"publisher","first-page":"20170550","DOI":"10.1259\/bjr.20170550","volume":"91","author":"SJ Oh","year":"2018","unstructured":"Oh SJ, et al. Relationship between background parenchymal enhancement on breast magnetic resonance imaging and pathological tumor response in breast cancer patients receiving neoadjuvant chemotherapy. Br J Radiol. 2018;91(1088):20170550.","journal-title":"Br J Radiol"},{"issue":"17","key":"566_CR12","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1200\/JCO.2010.33.0258","volume":"29","author":"AN Freedman","year":"2011","unstructured":"Freedman AN, et al. Benefit\/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol. 2011;29(17):2327.","journal-title":"J Clin Oncol"},{"issue":"15","key":"566_CR13","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"issue":"9","key":"566_CR14","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/COC.0000000000000388","volume":"41","author":"A Gupta","year":"2018","unstructured":"Gupta A, et al. Obesity is independently associated with increased risk of hepatocellular cancer\u2013related mortality. Am J Clin Oncol. 2018;41(9):874\u201381.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"566_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, et al. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280\u20136.","journal-title":"Ann Intern Med"},{"issue":"8","key":"566_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1634\/theoncologist.2015-0353","volume":"21","author":"S Sheikhbahaei","year":"2016","unstructured":"Sheikhbahaei S, et al. FDG-PET\/CT and magnetic resonance imaging for assessment of pathologic response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis of diagnostic accuracy studies. Oncologist. 2016;21(8):931\u20139.","journal-title":"Oncologist"},{"key":"566_CR17","doi-asserted-by":"crossref","unstructured":"Baltzer, P., et al. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy. in R\u00f6Fo-Fortschritte auf dem Gebiet der R\u00f6ntgenstrahlen und der bildgebenden Verfahren. 2011. \u00a9 Georg Thieme Verlag KG Stuttgart\u00b7 New York.","DOI":"10.1055\/s-0029-1246072"},{"issue":"6","key":"566_CR18","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.2214\/AJR.18.20566","volume":"212","author":"DA Sippo","year":"2019","unstructured":"Sippo DA, et al. Effect of background parenchymal enhancement on cancer risk across different high-risk patient populations undergoing screening breast magnetic resonance imaging. Am J Roentgenol. 2019;212(6):1412\u20138.","journal-title":"Am J Roentgenol"},{"issue":"6","key":"566_CR19","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1007\/s00330-017-5202-4","volume":"28","author":"JV Horvat","year":"2018","unstructured":"Horvat JV, et al. Apparent diffusion coefficient mapping using diffusion-weighted Magnetic resonance imaging: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis. Eur Radiol. 2018;28(6):2516\u201324.","journal-title":"Eur Radiol"},{"issue":"7","key":"566_CR20","doi-asserted-by":"publisher","first-page":"e0158573","DOI":"10.1371\/journal.pone.0158573","volume":"11","author":"B Bennani-Baiti","year":"2016","unstructured":"Bennani-Baiti B, Dietzel M, Baltzer PA. Magnetic resonance imaging background parenchymal enhancement is not associated with breast cancer. PLoS ONE. 2016;11(7):e0158573.","journal-title":"PLoS ONE"},{"issue":"11","key":"566_CR21","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00330-011-2175-6","volume":"21","author":"T Uematsu","year":"2011","unstructured":"Uematsu T, Kasami M, Watanabe J. Does the degree of background enhancement in breast magnetic resonance imaging affect the detection and staging of breast cancer? Eur Radiol. 2011;21(11):2261\u20137.","journal-title":"Eur Radiol"},{"issue":"1","key":"566_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/jmri.25338","volume":"45","author":"A Melsaether","year":"2017","unstructured":"Melsaether A, et al. Background parenchymal enhancement over exam time in patients with and without breast cancer. J Magn Reson Imaging. 2017;45(1):74\u201383.","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"566_CR23","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.ejrad.2015.06.023","volume":"84","author":"GY Cho","year":"2015","unstructured":"Cho GY, et al. Comparison of contrast enhancement and diffusion-weighted magnetic resonance imaging in healthy and cancerous breast tissue. Eur J Radiol. 2015;84(10):1888\u201393.","journal-title":"Eur J Radiol"},{"issue":"3","key":"566_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2214\/AJR.13.12146","volume":"204","author":"MJ DeLeo III","year":"2015","unstructured":"DeLeo MJ III, et al. Breast magnetic resonance imaging fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy. Am J Roentgenol. 2015;204(3):669\u201373.","journal-title":"Am J Roentgenol"},{"issue":"6","key":"566_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.clinimag.2015.08.001","volume":"39","author":"M Albert","year":"2015","unstructured":"Albert M, et al. The association of breast density in mammography and magnetic resonance imaging in high-risk women and women with breast cancer. Clin Imaging. 2015;39(6):987\u201392.","journal-title":"Clin Imaging"},{"issue":"12","key":"566_CR26","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1200\/JCO.18.00378","volume":"37","author":"VA Arasu","year":"2019","unstructured":"Arasu VA, et al. Population-based assessment of the association between magnetic resonance imaging background parenchymal enhancement and future primary breast cancer risk. J Clin Oncol. 2019;37(12):954\u201363.","journal-title":"J Clin Oncol"},{"issue":"6","key":"566_CR27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.5152\/dir.2017.17048","volume":"23","author":"G Arslan","year":"2017","unstructured":"Arslan G, et al. Background parenchymal enhancement: is it just an innocent effect of estrogen on the breast? Diagn Interv Radiol. 2017;23(6):414.","journal-title":"Diagn Interv Radiol"},{"issue":"1","key":"566_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00330-013-2993-9","volume":"24","author":"E Price","year":"2014","unstructured":"Price E, et al. The impact of bilateral salpingo-oophorectomy on breast magnetic resonance imaging background parenchymal enhancement and fibroglandular tissue. Eur Radiol. 2014;24(1):162\u20138.","journal-title":"Eur Radiol"},{"issue":"1","key":"566_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13058-015-0577-0","volume":"17","author":"S Wu","year":"2015","unstructured":"Wu S, et al. Quantitative assessment of background parenchymal enhancement in breast magnetic resonance imaging predicts response to risk-reducing salpingo-oophorectomy: preliminary assessment in a cohort of BRCA1\/2 mutation carriers. Breast Cancer Res. 2015;17(1):67.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"566_CR30","doi-asserted-by":"publisher","first-page":"10620","DOI":"10.18632\/oncotarget.13538","volume":"8","author":"X Hu","year":"2017","unstructured":"Hu X, et al. Quantitative assessment of background parenchymal enhancement in breast magnetic resonance images predicts the risk of breast cancer. Oncotarget. 2017;8(6):10620.","journal-title":"Oncotarget"},{"issue":"2","key":"566_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.mri.2015.10.014","volume":"34","author":"M Telegrafo","year":"2016","unstructured":"Telegrafo M, et al. Breast magnetic resonance imaging background parenchymal enhancement (background parenchymal enhancement) correlates with the risk of breast cancer. Magn Reson Imaging. 2016;34(2):173\u20136.","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"566_CR32","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1038\/s41598-017-02341-8","volume":"7","author":"S Wu","year":"2017","unstructured":"Wu S, et al. DCE-Magnetic resonance imaging background parenchymal enhancement quantified from an early versus delayed post-contrast sequence: association with breast cancer presence. Sci Rep. 2017;7(1):2115.","journal-title":"Sci Rep"},{"issue":"1","key":"566_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.acra.2018.03.013","volume":"26","author":"LJ Grimm","year":"2019","unstructured":"Grimm LJ, et al. Relationship between background parenchymal enhancement on high-risk screening magnetic resonance imaging and future breast cancer risk. Acad Radiol. 2019;26(1):69\u201375.","journal-title":"Acad Radiol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-021-00566-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12880-021-00566-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-021-00566-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T22:27:23Z","timestamp":1613860043000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-021-00566-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1186\/s12880-021-00566-8","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"assertion":[{"value":"18 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}